Six Minute Walk Test to assess functional capacity in chronic liver disease patients

Table 2 Characteristics of liver cirrhosis patients in terms of those who survived and those who had died during the study period

Variable		Non-survivors (n = 15)	Survivors (n = 83)	P
Age (yr)		61 ± 10	55 ± 11	0.064
CP score		10.0 ± 2.3	8.5 ± 2.2a	0.016
6MWD (m)		245 ± 145	317 ± 101a	0.021
O2%	Baseline	97.3 ± 1.7	97.9 ± 1.5	0.21
	End	97.4 ± 3.0	97.2 ± 1.6	0.64
Hemoglobin (g/L)		114.7 ± 14.7	127.6 ± 17.7b	0.009
Prothrombin time (s)		16.1 ± 5.6	16.5 ± 4.5	0.82
ALT (U/L)		90.5 ± 82.7	85.4 ± 59.5	0.77
AST (U/L)		107.1 ± 62.6	92.3 ± 79.4	0.50
ALP (U/L)		242.2 ± 141.8	169.5 ± 124.7	0.45
Albumin (g/L)		24.2 ± 5.6	29.0 ± 6.6a	0.011
Bilirubin (μmol/L)		67.4 ± 65.1	40.1 ± 56.9	0.098
Creatinine (μmol/L)		114.4 ± 86.0	81.7 ± 18.0b	0.002

ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; CP: Child Pugh; GGT: gamma glutamyl transpeptidase.

^aP < 0.05,

^bP < 0.01 vs non-survivors.